New Antifungal Drugs, New Approaches and Vaccines

Turbinmicin

F901318 (olorofim)

Ibrexafungerp (SCY-078, MK-3118)

YO-001A, a new antifungal agent produced by Streptomyces sp. YO15-A001

In vitro

6 October 2019

Ibrexafungerp Overview

3 July 2019

Study to Evaluate the Safety and Efficacy of the Combination Therapy of Ibrexafungerp (SCY-078) With Voriconazole in Patients With Invasive Pulmonary Aspergillosis (SCYNERGIA)

Phase 2

22 January 2019

Open-Label Study to Evaluate Efficacy and Safety of SCY-078 in Patients With Refractory or Intolerant Fungal Diseases (FURI)

Phase 3

1 April 2017

In vitro activity of olorofim (F901318) against clinical isolates of cryptic species of Aspergillus by EUCAST and CLSI methodologies.

25 March 2019

Activity of Ceragenin CSA-131 against Candida Auris

9 April 2018

Preclinical Evaluation of the Stability, Safety and Efficacy of CD101, a Novel Echinocandin

In vivo

1 November 2017